Article
The rate of accumulation of nonnucleoside reverse transcriptase inhibitor (NNRTI) resistance in patients kept on a virologically failing regimen containing an NNRTI*.
HIV medicine - 1 Jan 2012
Cozzi-Lepri A, Paredes, Phillips A N, Clotet B, Kjaer J, Von Wyl V, Kronborg G, Castagna A, Bogner J R, Lundgren J D
Abstract excerpt
BACKGROUND: Virological failure of first-generation nonnucleoside reverse transcriptase inhibitors (NNRTIs) can compromise the efficacy of etravirine as a result of the accumulation of NNRTI resistance mutations. How quickly NNRTI resistance accumulates in patients with a delayed switch from nevirapine or efavirenz despite virological failure, when these drugs are used as a component of combination antiretroviral...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
